Latest On Grifols, S.A (GIFOF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2021-06-03 06:11 EST | Dividend | A dividend of $0.01 has been announced on May 21, 2021. It will be paid Jun 7, 2021 with an ex-dividend date of Jun 3, 2021. | Neutral |  |
| 2021-03-02 01:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 22:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 01:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 13:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-26 05:57 EST | Dividend | A dividend of $0.01 has been announced on N/A. It will be paid Oct 28, 2020 with an ex-dividend date of Oct 26, 2020. | Neutral | |
| 2020-09-26 14:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 14:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-02 19:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 18:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 22:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 10:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 06:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 07:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 02:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 07:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 18:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-27 02:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-23 18:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-23 06:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 06:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-09 22:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 22:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 22:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-18 21:58 EST | Stock Split | A stock split has occured on Jan 4, 2016 with a split factor of 2:1. | Neutral | |
| 2020-02-28 05:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-27 23:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-22 01:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-21 00:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-18 01:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-13 01:26 EST | Financials | Company financials have been released. | Neutral | |
About Grifols, S.A (GIFOF):
Grifols, S.A. develops, manufactures, and distributes a range of biological medicines on plasma derived proteins worldwide. The company operates through five segments: Bioscience, Diagnostic, Hospital, Bio Supplies, and Others. The Bioscience segment manufactures plasma derivatives for therapeutic use; and sells and distributes end products. It offers plasma products, such as intravenous immune globulin, Factor VIII, alpha-1 proteinase inhibitor, and albumin; and intramuscular immunoglobulins, antithrombin III, Factor IX, and plasma thromboplastin components. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products, including analytical instruments, reagents, software, and related products for use in clinical and blood bank laboratories. It serves blood donation centers, clinical analysis laboratories, and hospital immunohematology services. The Hospital segment offers products used by hospitals, as well as parenteral solutions and enteral nutritional fluids. The Bio Supplies segment provides biological products for non-therapeutic uses. The Others segment renders manufacturing services to third party companies. The company also provides infusion solutions, nutrition products, and medical devices for use in hospitals and clinics; and engineering services. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves hospitals and clinics, group purchasing organizations, governments, and other distributors through sales representatives, marketing partners, and third-party distributors. Grifols, S.A. has a technology collaboration agreement with Mondragon to jointly develop healthcare sector-related automation, robotics, and instrumentation, as well as other technologies and infrastructure. The company was founded in 1940 and is headquartered in Barcelona, Spain.
General
- Name Grifols, S.A
- Symbol GIFOF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorOther
- IndustryOther
- Full Time Employees 22,000
- Fiscal Year EndDecember
Valuation
- Trailing PE 15.87
- Forward PE 12.44
- Price/Sales (Trailing 12 Mt.) 1.79
- Price/Book (Most Recent Quarter) 1.87
- Enterprise Value Revenue 4.27
- Enterprise Value EBITDA 16.03
Financials
- Most Recent Quarter 2020-12-31
- Earnings Per Share $1.20
- Revenue Per Share $0
- Gross Profit 2.05 billion
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 14.81 billion
- PE Ratio 26.19
- PEG Ratio 1.84
- Book Value Per Share $7.12
Share Statistics
- % Held by Insiders <1%
Technicals
- 52 Week High $20.77
- 52 Week Low $14.77
- 50 Day Moving Average 16.68
- 200 Day Moving Average 17.84
Dividends
- Payout Ratio 27%
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Per Share $0.39
- Dividend Yield 0%
Grifols, S.A (GIFOF) Dividend Calendar:
Grifols, S.A pays out 27% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Grifols, S.A (GIFOF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-12-31 | $1.35 billion | $0.23 | ||
| 2020-06-30 | 2020-09-30 | $1.38 billion | $0.46 | $0.16 | 184.81% |
| 2020-03-31 | 2020-06-30 | $1.29 billion | $0.06 | $0.26 | -78.38% |
| 2019-12-31 | 2020-03-31 | $1.36 billion | $0.30 | $0.30 | -0.8% |
| 2019-09-30 | 2019-12-31 | $1.31 billion | $0.32 | $0.28 | 15.64% |
| 2019-06-30 | 2019-09-30 | $1.27 billion | $0.22 | $0.28 | -22.14% |
| 2019-03-31 | 2019-06-30 | $1.16 billion | $0.28 | $0.23 | 23.61% |
| 2018-12-31 | 2019-03-31 | $1.22 billion | $0.19 | $0.26 | -26.65% |
| 2018-09-30 | 2018-12-31 | $892.76 million | $0.21 | $0.26 | -20.15% |
| 2018-06-30 | 2018-09-30 | $9.89 million | $0.26 | $0.26 | -1.77% |
| 2018-03-31 | 2018-06-30 | $1.02 billion | $0.30 | $0.22 | 38% |
| 2017-12-31 | 2018-03-31 | $307.74 million | $0.26 | $0.25 | 3.48% |
| 2017-09-30 | 2017-12-31 | $1.06 billion | $0.41 | $0.22 | 85% |
| 2017-06-30 | 2017-09-30 | $1.13 billion | $0.26 | $0.26 | -0.15% |
| 2017-03-31 | 2017-06-30 | $1.06 billion | $0.24 | $0.23 | 4.3% |
| 2016-12-31 | 2017-03-31 | $1.1 billion | $0.21 | $0.22 | -3% |
| 2016-09-30 | 2016-12-31 | $0.22 | $0.22 | -0.18% | |
| 2016-06-30 | 2016-09-30 | $0.24 | $0.22 | 7.23% | |
| 2016-03-31 | 2016-06-30 | $0.22 | $0.20 | 11.05% | |
| 2015-12-31 | 2016-03-31 | $0.21 | $0.24 | -14.58% | |
| 2015-09-30 | 2015-12-31 | $0.20 | $0.22 | -6.91% | |
| 2015-06-30 | 2015-09-30 | $0.22 | $0.20 | 11.6% | |
| 2015-03-31 | 2015-06-30 | $0.21 | $0.19 | 11.37% | |
| 2014-12-31 | 2015-03-31 | $0.20 | $0.23 | -11.26% | |
| 2014-09-30 | 2014-12-31 | $0.23 | $0.21 | 10.14% | |
| 2014-06-30 | 2014-09-30 | $0.21 | |||
| 2014-03-31 | 2014-06-30 | $0.21 | |||
| 2013-12-31 | 2014-03-31 | $0.24 | |||
| 2013-09-30 | 2013-12-31 | $0.15 | |||
| 2013-06-30 | 2013-09-30 | $0.17 | |||
| 2013-03-31 | 2013-06-30 | $0.18 | |||
| 2012-12-31 | 2013-03-31 | $0.17 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.11 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.12 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.12 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.13 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.01 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.05 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | -$0.04 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $0.11 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.06 | $0.00 |
Grifols, S.A (GIFOF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | 80.75 million | 71.35 million | 74.25 million | 67.87 million | 75.03 million |
| Income Before Tax | 202.63 million | 348.86 million | 75.87 million | 251.28 million | 259.1 million |
| Selling General Administrative | 261.35 million | 239.9 million | 233.78 million | 250.59 million | 246.65 million |
| Gross Profit | 590.53 million | 626.02 million | 447.38 million | 591.23 million | 608.62 million |
| Ebit | 374.52 million | 448.52 million | 211.77 million | 350.36 million | 361.87 million |
| Operating Income | 248.43 million | 314.77 million | 139.36 million | 272.78 million | 286.94 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | 1.31 billion | 1.35 billion | 1.38 billion | 1.29 billion | 1.36 billion |
| Cost of Revenue | 718.8 million | 727.35 million | 936.64 million | 702.09 million | 752.29 million |
| Total Other Income Expense Net | 62.34 million | 45.86 million | -3.74 million | -4.66 million | -64.46 million |
| Net Income From Continuing Operations | 161.43 million | 285.88 million | 58.14 million | 203.54 million | 202.24 million |
| Net Income Applicable to Common Shares | N/A | N/A | N/A | N/A | N/A |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -83.09 million | -109.76 million | -113.31 million | -155.65 million | 142.76 million |
| Change to Liabilities | N/A | N/A | N/A | N/A | 23.05 million |
| Total Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | 38.82 million |
| Net Borrowings | N/A | N/A | N/A | N/A | -49.22 million |
| Total Cash Flow from Financial Activities | -42.81 million | -68.38 million | -110.04 million | -92.75 million | -39.41 million |
| Change to Operating Activities | N/A | N/A | N/A | N/A | -7.31 million |
| Change in Cash | 187.87 million | 254.4 million | -117.98 million | 1.73 million | 238.44 million |
| Total Cash from Operating Activities | 310.97 million | 435.34 million | N/A | N/A | 193.66 million |
| Depreciation | 80.87 million | 80.64 million | 77.57 million | 78.33 million | 75.19 million |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | -18.93 million |
| Change to Inventory | 8.58 million | 325.56 million | -74.68 million | -70.73 million | -43.48 million |
| Change to Account Receivables | N/A | N/A | 1.34 million | N/A | 39.78 million |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | 9.81 million |
| Change to Net Income | N/A | N/A | N/A | N/A | -30.09 million |
| Capital Expenditures | 77.06 million | 96.64 million | 86.4 million | 157.84 million | 69.22 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 8.55 billion | 8.54 billion | 8.56 billion | 8.69 billion | 8.7 billion |
| Total Stockholder Equity | 5.11 billion | 5.35 billion | 5.36 billion | 5.54 billion | 4.82 billion |
| Other Current Liabilities | 105.04 million | 1.24 billion | 217.39 million | 1.33 billion | 41.77 million |
| Total Assets | 15.27 billion | 15.65 billion | 15.6 billion | 15.9 billion | 15.54 billion |
| Common Stock | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | 51.75 million | 43.76 million | 43.37 million | 45.93 million | 58.11 million |
| Retained Earnings | 618.55 million | 485.68 million | 218.25 million | 186.38 million | 625.15 million |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A |
| Cash | 579.65 million | 1.03 billion | 878.41 million | 637.7 million | 741.98 million |
| Total Current Liabilities | 1.34 billion | 1.24 billion | 1.24 billion | 1.33 billion | 1.37 billion |
| Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | 3.16 billion | 3.64 billion | 3.55 billion | 3.66 billion | 5.36 billion |
| Long Term Investments | 2.07 billion | 2.04 billion | 2.07 billion | 2.09 billion | 143.98 million |
| Net Tangible Assets | N/A | N/A | N/A | N/A | N/A |
| Short Term Investments | 10.86 million | 12.29 million | 12.32 million | 13.04 million | 1.73 billion |
| Long Term Debt | 5.9 billion | N/A | 6.09 billion | N/A | 6.09 billion |
| Inventory | 2 billion | 1.99 billion | 2.09 billion | 2.46 billion | 2.34 billion |
| Accounts Payable | 601.62 million | N/A | 551.91 million | N/A | 581.88 million |
Grifols, S.A (GIFOF) Chart:
Grifols, S.A (GIFOF) News:
Below you will find a list of latest news for Grifols, S.A (GIFOF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Grifols, S.A (GIFOF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Grifols, S.A (GIFOF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|